Contents
Academy · Research Writing · WHO clinical registry standards
WHO Clinical Trial Registry Standards: The Trial Registration Data Set and Prospective Registration
A trial that is not registered to a defined data standard before it begins cannot subsequently demonstrate that its outcomes were not selected after the fact. This is the fundamental rationale for the WHO standard.
The World Health Organization's Trial Registration Data Set is the minimum set of data items a clinical trial registry must be able to collect and publicly display for a trial to be considered adequately registered under WHO standards, and it underlies the WHO International Clinical Trials Registry Platform (ICTRP), which aggregates registrations from WHO-recognised primary registries worldwide.
Learning objectives
- What the WHO Trial Registration Data Set requires, and why it constitutes a minimum standard rather than a recommendation.
- How WHO-recognised primary registries and the ICTRP search portal relate to each other.
- Why prospective registration, before enrolment begins, is the essential requirement.
- The risks against which registration to this standard protects.
Common misconceptions
- “Any public listing of a trial counts as adequate registration.” WHO defines a specific minimum data set a registry must be able to collect and display; a registry that cannot capture these items is not a WHO-recognised primary registry, and a trial listed only there does not meet the standard most journals and funders require.
- “Registering a trial after it starts enrolling still counts as proper registration.” The protective purpose of trial registration, which is to allow external parties to verify that outcomes were defined before results were known, depends specifically on prospective registration, before the first participant is enrolled.
The WHO Trial Registration Data Set
The World Health Organization requires that any registry seeking recognition as a primary registry under its network be able to collect and publicly display the WHO Trial Registration Data Set — a defined set of data items covering, among others, the trial's unique identifying number, the sponsor and funding source, the health condition studied, the intervention and comparator, key eligibility criteria, primary and secondary outcomes, target sample size, recruitment status, and key trial dates. The standard exists so that, regardless of which national or regional registry a trial is listed in, the same baseline information is available and comparable.
Primary registries and the International Clinical Trials Registry Platform (ICTRP)
The WHO International Clinical Trials Registry Platform (ICTRP) is a search portal that aggregates trial records from the network of primary registries the WHO has formally recognised as meeting its registry criteria, including the capacity to collect the full Trial Registration Data Set. A trial registered in any WHO-recognised primary registry is therefore findable through the ICTRP search portal, which enables systematic reviewers, journal editors and funders to verify registration status without needing to know in advance which specific national registry a given trial used.
Prospective registration as the essential requirement
Registering a trial’s design, including its pre-specified primary and secondary outcomes, before the first participant is enrolled is what gives registration its protective function: it creates a timestamped, public record of what the trial intended to measure, against which the eventual published report can be checked. Registering after enrolment has begun, or, more seriously, after results are known, undermines this function regardless of how complete the eventual registry entry is, which is why journal and funder policies that require registration specifically require prospective registration, not registration at any point in a trial’s life.
Key points
Key points
WHO's Trial Registration Data Set defines the minimum information a primary registry must collect and display, and the ICTRP aggregates records across the WHO-recognised registry network so a trial's registration is findable regardless of which registry it used -- but the standard's protective value depends specifically on registering prospectively, before enrolment starts, not merely on registering at some point.
Practical application
Practical application
- Registration should precede enrolment of the first participant. Prospective registration should be treated as a firm deadline tied to first enrolment, since later registration undermines the protective purpose of the record regardless of its completeness.
- A WHO-recognised primary registry should be used. The chosen registry should be confirmed as part of the WHO primary registry network and capable of capturing the full Trial Registration Data Set, unlike a listing service that cannot.
- Outcomes in the registry entry should remain consistent with the eventual manuscript. Any change to primary or secondary outcomes after registration should be documented and explained in the published report, not silently introduced.
Frequently asked questions
Yes; ClinicalTrials.gov and a number of other national and regional registries are part of the WHO primary registry network and feed into the ICTRP.
Most journal and funder policies expect such changes to be disclosed and explained in the published report, since an undisclosed change undermines the purpose of having registered the original outcomes in the first place.
No; the WHO standard and most journal policies apply to clinical trials broadly, including non-pharmacological interventions, though specific registry and reporting requirements can vary by trial type.
References
- World Health Organization. International Clinical Trials Registry Platform (ICTRP): Registry Criteria. read 10 October 2026. View WHO ICTRP registry criteria
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). WHO Clinical Trial Registry Standards: The Trial Registration Data Set and Prospective Registration. Pubrica. https://pubrica.com/academy/concepts-definitions/who-clinical-registry-standards/
Pubrica Academy. “WHO Clinical Trial Registry Standards: The Trial Registration Data Set and Prospective Registration.” Pubrica, 10 Oct. 2026, pubrica.com/academy/concepts-definitions/who-clinical-registry-standards/.
Pubrica Academy (2026) WHO Clinical Trial Registry Standards: The Trial Registration Data Set and Prospective Registration. Pubrica. Available at: https://pubrica.com/academy/concepts-definitions/who-clinical-registry-standards/ (Accessed: 15 October 2026).
Pubrica Academy. “WHO Clinical Trial Registry Standards: The Trial Registration Data Set and Prospective Registration.” Pubrica. October 10, 2026. https://pubrica.com/academy/concepts-definitions/who-clinical-registry-standards/
Pubrica Academy, ‘WHO Clinical Trial Registry Standards: The Trial Registration Data Set and Prospective Registration’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/concepts-definitions/who-clinical-registry-standards/> accessed 15 October 2026.
Pubrica Academy. WHO Clinical Trial Registry Standards: The Trial Registration Data Set and Prospective Registration. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/concepts-definitions/who-clinical-registry-standards/
Pubrica Academy, “WHO Clinical Trial Registry Standards: The Trial Registration Data Set and Prospective Registration,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/concepts-definitions/who-clinical-registry-standards/
@misc{who_clinical_registry_standards_2026,
author = {{Pubrica Academy}},
title = {WHO Clinical Trial Registry Standards: The Trial Registration Data Set and Prospective Registration},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/concepts-definitions/who-clinical-registry-standards/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Trial registration pre-enrolment checklist
This checklist should be used before the first participant is enrolled.
[ ] WHO-recognised primary registry selected [ ] All WHO Trial Registration Data Set items completed [ ] Primary and secondary outcomes specified exactly as intended for analysis [ ] Registration completed before first participant enrolled [ ] Registration number recorded for use in the eventual manuscript
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s research-writing team manages trial registration against the WHO Trial Registration Data Set before enrolment, and reconciles the outcomes of the published manuscript with the registered record so that any changes are documented rather than identified by a reviewer.